ExcelFin Acquisition Corp.
Status: Deal Closed
U=S+W/2
W=S@11.50
IPO Proceeds, $M | $230.00M |
---|---|
IPO Date | Oct 21, 2021 |
CEO | Joe Ragan |
Left Lead | UBS |
IPO Cash in Trust | 102.0% |
SPAC Tenor | 18 + 6 + 6 + 3 + 5 |
IPO Sector |
Financial
U.S. domiciled Financial Technology |
IPO Geography | US/Canada |
Target Company | Baird Medical |
Deal Announced | Jun 26, 2023 |
Deal Size, $M | $279.00M |
Deal Sector | Healthcare |
Deal Geography | Asia |
SEC Filings | www.sec.gov |
Approval Vote | Sep 26, 2024 |
Amendment Vote | Jul 24, 2024 |
Closing Date | Oct 1, 2024 |
Formerly XFIN
BDMD
BDMDW
Price | $2.88 |
---|---|
Last closing price | $2.42 |
H/L, today | $2.10 / $2.48 |
Volume, today | 50,813 |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on ExcelFin Acquisition Corp.:
- Structure and cap table
- 8 directors & officers
- 48 filings and events
- 3 underwriters
- 2 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Jennifer Hill | 55 | Chairman of the Board |
Joe Ragan | 61 | CEO and Director |
Brian Sun | 48 | COO |
Joe Ragan | 59 | Chief Financial Officer |
Brian Sun | 45 | Executive Vice President |
Gary Meltzer | 57 | Director |
Neil Wolfson | 56 | Director |
Goh Lin Piao | 56 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
UBS | BR | 15,000,000 | units |
EXOS Securities | 4,000,000 | ||
KeyBanc Capital Markets | 1,000,000 | ||
20,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.